Molecular cloning of a novel type of rat cytoplasmic 17β-hydroxysteroid dehydrogenase distinct from the type 5 isozyme
Molecular cloning of a novel type of rat cytoplasmic 17β-hydroxysteroid dehydrogenase distinct from the type 5 isozyme
复制标题
DOI:
10.1093/jb/mvj109
复制
发表时间:
2006-06-01
影响因子:
2.7
通讯作者:
Hara, Akira
中科院分区:
文献类型:
--
作者:
Ishikura, Shuhei;Matsumoto, Kengo;Hara, Akira
Rat liver contains two cytosolic enzymes (TBER1 and TBER2) that reduce 6-tert-butyl-2,3-epoxy-5-cyclohexene-1,4-dione into its 4R- and 4S-hydroxy metabolites. In this study, we cloned the cDNA for TBER1 and examined endogenous substrates using the homogenous recombinant enzyme. The cDNA encoded a protein composed of 323 amino acids belonging to the aldo-keto reductase family. The recombinant TBER1 efficiently oxidized 17 beta-hydroxysteroids and xenobiotic alicyclic alcohols using NAD(+) as the preferred coenzyme at pH 7.4, and showed low activity towards 20 alpha- and 3 alpha-hydroxysteroids, and 9-hydroxyprostaglandins. The enzyme was potently inhibited by diethylstilbestrol, hexestrol and zearalenone. The coenzyme specificity, broad substrate specificity and inhibitor sensitivity of the enzyme differed from those of rat NADPH-dependent 17 beta-hydroxysteroid dehydrogenase type 5, which was cloned from the liver and characterized using the recombinant enzyme. The mRNA for TBER1 was highly expressed in rat liver, gastrointestinal tract and ovary, in contrast to specific expression of 17 beta-hydroxysteroid dehydrogenase type 5 mRNA in the liver and kidney. Thus, TBER1 represents a novel type of 17 beta-hydroxysteroid dehydrogenase with unique catalytic properties and tissue distribution. In addition, TBER2 was identified as 3 alpha-hydroxysteroid dehydrogenase on chromatographic analysis of the enzyme activities in rat liver cytosol and characterization of the recombinant 3 alpha-hydroxysteroid dehydrogenase.